Marinus Pharmaceuticals (LTS:0JYL) Other Gross PPE : $4.88 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Marinus Pharmaceuticals Other Gross PPE?

Marinus Pharmaceuticals's Other Gross PPE for the quarter that ended in Sep. 2024 was $4.88 Mil.

Marinus Pharmaceuticals's quarterly Other Gross PPE declined from Mar. 2024 ($3.74 Mil) to Jun. 2024 ($3.72 Mil) but then increased from Jun. 2024 ($3.72 Mil) to Sep. 2024 ($4.88 Mil).

Marinus Pharmaceuticals's annual Other Gross PPE increased from Dec. 2021 ($3.46 Mil) to Dec. 2022 ($5.18 Mil) and increased from Dec. 2022 ($5.18 Mil) to Dec. 2023 ($5.23 Mil).

Marinus Pharmaceuticals Other Gross PPE Historical Data

The historical data trend for Marinus Pharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinus Pharmaceuticals Other Gross PPE Chart

Marinus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

2.68

3.46

5.18

5.23

Marinus Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Gross PPE	Get a 7-Day Free Trial															3.91	5.23	3.74	3.72	4.88

Marinus Pharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Marinus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinus Pharmaceuticals Inc (LTS:0JYL) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Matsonford Road, Suite 500, 5 Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.marinuspharma.com

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Marinus Pharmaceuticals Headlines

No Headlines